{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:13:25Z","timestamp":1791051205578,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.neulet.2012.04.046","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T16:57:36Z","timestamp":1335373056000},"page":"136-139","source":"Crossref","is-referenced-by-count":71,"title":["Association between a variant of the sigma-1 receptor gene and Alzheimer's disease"],"prefix":"10.1016","volume":"517","author":[{"given":"\u00c1gnes","family":"Feh\u00e9r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"L\u00e1szl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J\u00e1nos","family":"K\u00e1lm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolna","family":"P\u00e1k\u00e1ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"K\u00e1lm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Janka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2012.04.046_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1016\/j.neulet.2012.04.046_bib0010","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.neulet.2012.04.046_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exer.2005.06.008","article-title":"Focus on molecules: the sigma-1 receptor","volume":"81","author":"Duncan","year":"2005","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.neulet.2012.04.046_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YPG.0b013e3283457bcc","article-title":"No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population","volume":"21","author":"Feh\u00e9r","year":"2011","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/j.neulet.2012.04.046_bib0025","first-page":"788","article-title":"Ca2+ signaling via sigma 1 receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neulet.2012.04.046_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(98)00797-6","article-title":"Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia","volume":"257","author":"Ishiguro","year":"1998","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neulet.2012.04.046_bib0035","first-page":"S31","article-title":"Mapping of sigma1 receptors by 11C-SA4503-distribution and aging effect in normal human brain","volume":"16","author":"Ishii","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2012.04.046_bib0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(93)91441-T","article-title":"Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss","volume":"623","author":"Jansen","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.neulet.2012.04.046_bib0045","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0197-4580(02)00152-5","article-title":"An increase of sigma receptors in the aged monkey brain","volume":"24","author":"Kawamura","year":"2003","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neulet.2012.04.046_bib0050","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.02.013","article-title":"Association analysis of SIGMAR1 with major depressive disorder and SSRI response","volume":"58","author":"Kishi","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2012.04.046_bib0055","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","article-title":"Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity","volume":"16","author":"Marrazzo","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2012.04.046_bib0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000101990","article-title":"Sigma receptor type 1 gene expression variation in a group of Polish patients with Alzheimer's disease and mild cognitive impairment","volume":"23","author":"Maruszak","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.neulet.2012.04.046_bib0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.neulet.2012.04.046_bib0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2012.04.046_bib0075","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid \u03b225\u201335 peptide-induced toxicity in mice involve an interaction with the \u03c31 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neulet.2012.04.046_bib0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma1 receptors in early Alzheimer's disease","volume":"22","author":"Mishina","year":"2008","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/j.neulet.2012.04.046_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2003.07.008","article-title":"Functional polymorphisms in the sigma1 receptor gene associated with alcoholism","volume":"55","author":"Miyatake","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neulet.2012.04.046_bib0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.neulet.2012.04.046_bib0095","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00019442-200512000-00005","article-title":"A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease","volume":"13","author":"Uchida","year":"2005","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.neulet.2012.04.046_bib0100","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/npp.2008.212","article-title":"Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25\u201335)-induced toxicity in mice","volume":"34","author":"Villard","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2012.04.046_bib0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbr.2009.12.043","article-title":"The cholinergic system, sigma-1 receptors and cognition","volume":"221","author":"van Waarde","year":"2011","journal-title":"Behavioural Brain Research"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012005800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012005800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T19:12:40Z","timestamp":1561662760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394012005800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0304394012005800"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2012.04.046","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}